First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.26 USD -4.05%
Updated: Apr 26, 2024

ADC Therapeutics SA
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ADC Therapeutics SA
Accumulated Depreciation Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Accumulated Depreciation
-$4.3m
CAGR 3-Years
-2%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Accumulated Depreciation
-CHf11m
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Accumulated Depreciation
-$53.4m
CAGR 3-Years
-36%
CAGR 5-Years
-48%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Accumulated Depreciation
-CHf10.9m
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Accumulated Depreciation
-CHf96.9m
CAGR 3-Years
-27%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Accumulated Depreciation?
Accumulated Depreciation
-4.3m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Accumulated Depreciation amounts to -4.3m USD.

What is ADC Therapeutics SA's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-34%

Over the last year, the Accumulated Depreciation growth was -30%. The average annual Accumulated Depreciation growth rates for ADC Therapeutics SA have been -2% over the past three years , -34% over the past five years .